Try our Advanced Search for more refined results

Aspen Pays $263M For GSK's Zantac, Other OTC Drugs

By Liz Hoffman (April 20, 2012, 12:10 PM EDT) -- GlaxoSmithKline PLC will sell five international over-the-counter drug brands including antacid Zantac for £164 million ($263 million) to South Africa's Aspen Pharmacare Holdings Ltd., GSK said Friday, the third such sale in four months as the company prunes its consumer product line....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!